Most common cancer in us
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that the most common cancers in the US are breast, prostate, and colorectal cancer.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Most Common Cancer in the United States
Overview of Cancer Incidence and Mortality
Cancer remains a significant public health issue in the United States, with millions of new cases diagnosed each year. In 2023, it is projected that there will be approximately 1,958,310 new cancer cases and 609,820 cancer deaths in the U.S.. The most common cancers include breast, prostate, lung, and colorectal cancers, which have consistently been the leading diagnoses over the years.
Leading Cancer Types
Breast Cancer
Breast cancer is one of the most frequently diagnosed cancers in the United States. It is particularly prevalent among women, with incidence rates continuing to rise. In 2023, breast cancer remains a leading cause of cancer diagnosis and death among women. Advances in screening and treatment have contributed to improved survival rates, but the disease still poses a significant burden.
Prostate Cancer
Prostate cancer is the most common cancer among men in the United States. After a period of decline, the incidence of prostate cancer has been increasing by 3% annually from 2014 through 2019, resulting in a significant number of new cases. Despite this increase, mortality rates have been declining due to better detection and treatment options.
Lung Cancer
Lung cancer is the leading cause of cancer death in the United States, accounting for more deaths than breast, prostate, colorectal, and brain cancers combined. Although the incidence and mortality rates for lung cancer have been declining, it remains a major health concern. The decline in lung cancer deaths has been attributed to reductions in smoking rates and advancements in early detection and treatment .
Colorectal Cancer
Colorectal cancer is the second most common cause of cancer death in the United States . The incidence of colorectal cancer has been decreasing among older adults due to increased screening, but it has been rising among younger adults. In 2023, approximately 153,020 new cases of colorectal cancer are expected, with 52,550 deaths projected. The shift towards younger age at diagnosis and more advanced stages of the disease highlights the need for continued research and improved screening strategies.
Emerging Trends
Thyroid, Liver, and Pancreatic Cancers
Projections indicate that thyroid cancer will become the fourth leading cancer diagnosis by 2030, surpassing colorectal cancer. Additionally, liver and pancreatic cancers are expected to become the second and third leading causes of cancer-related deaths, respectively, by 2030. These trends underscore the importance of focusing on these cancers for future research and healthcare planning.
Brain and Central Nervous System Tumors
Primary brain and other central nervous system (CNS) tumors, including glioblastoma and meningioma, are significant contributors to cancer morbidity and mortality. The incidence rates for these tumors are higher in females compared to males and vary by race and ethnicity . Despite being less common than other cancers, brain and CNS tumors have a substantial impact due to their often severe outcomes and lower survival rates.
Conclusion
Breast, prostate, lung, and colorectal cancers remain the most common cancers in the United States, with significant incidence and mortality rates. Emerging trends indicate a rising burden of thyroid, liver, and pancreatic cancers, as well as brain and CNS tumors. Continued efforts in research, early detection, and treatment are essential to address these challenges and improve cancer outcomes.
Sources and full results
Most relevant research papers on this topic
